Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH) | Zendy

Pejman Cohan | Zendy; Honey E. East | Zendy; Sandi-Jo Galati | Zendy; Jennifer U. Mercado | Zendy; Precious J Lim | Zendy; Michele Lamerson | Zendy; James J. Smith | Zendy; Anne L. Peters | Zendy; Kevin C.J. Yuen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH)

Author(s) -

Pejman Cohan,

Honey E. East,

Sandi-Jo Galati,

Jennifer U. Mercado,

Precious J Lim,

Michele Lamerson,

James J. Smith,

Anne L. Peters,

Kevin C.J. Yuen

Publication year - 2019

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2018-02638

Subject(s) - mifepristone , medicine , adrenalectomy , adverse effect , surgery , cushing syndrome , pregnancy , genetics , biology

Primary bilateral macronodular adrenal hyperplasia (BMAH) is a rare form of adrenal Cushing syndrome conventionally treated with adrenalectomy. Medical treatment is often reserved for patients not eligible for surgery. However, to date there have been few studies about the efficacy of mifepristone for the treatment of BMAH associated with hypercortisolism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research